Investigating the kynurenine pathway in pediatric metabolic health

Fatma Özgüç Çömlek1, Dilek Bingöl Aydın2, Fikret Akyürek3

  • 1485663 Selçuk Üniversity, Medical Faculty, Pediatric Endocrinology , Konya, Türkiye.

Insights

Pediatric obesity alters tryptophan metabolism, with higher levels observed in obese children. The 3-hydroxykynurenine/kynurenine ratio correlated with metabolic syndrome indicators, suggesting a potential link.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Health
  • Biochemistry

Background:

  • Childhood obesity is a growing concern, linked to increased metabolic disease incidence.
  • Tryptophan (TRP) metabolism, particularly the kynurenine pathway, is implicated in obesity-related inflammation.
  • Indoleamine 2,3-dioxygenase (IDO) activity influences TRP catabolism and inflammatory processes.

Purpose of the Study:

  • To investigate the impact of pediatric obesity on tryptophan metabolism.
  • To explore the association between altered tryptophan metabolites and metabolic syndrome indicators in children.
  • To assess changes in kynurenine pathway metabolites in relation to obesity severity.

Main Methods:

  • Prospective cohort study of 86 children (≥10 years), including 56 obese participants.
  • Obese children classified into obese and severely obese groups based on BMI percentiles.
  • Serum kynurenine pathway metabolites analyzed using liquid chromatography-mass spectrometry/mass spectrometry.

Main Results:

  • Obese children exhibited significantly higher plasma tryptophan levels compared to non-obese peers.
  • The metabolite 3-hydroxykynurenine (3HK) and the 3HK/kynurenine (KYN) ratio were significantly elevated in obese children.
  • Higher 3HK/KYN ratios correlated with increased triglycerides, GGT, HDL levels, and elevated systolic and diastolic blood pressure.

Conclusions:

  • Pediatric obesity is associated with alterations in plasma kynurenine pathway metabolites.
  • The 3HK/KYN ratio shows a correlation with key metabolic syndrome indicators in obese children.
  • Further research with larger cohorts is necessary to confirm the link between these metabolites and metabolic syndrome in pediatric obesity.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
185
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
690
Biosynthesis of Nucleic Acids01:28

Biosynthesis of Nucleic Acids

Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
946
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
201
Regulation of Metabolism01:19

Regulation of Metabolism

Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
11.4K
Amino Acid Biosynthetic Pathways01:29

Amino Acid Biosynthetic Pathways

Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which...
1.0K